|Bid||44.00 x 1200|
|Ask||44.44 x 1000|
|Day's Range||44.39 - 45.40|
|52 Week Range||42.01 - 58.31|
|Beta (3Y Monthly)||1.68|
|PE Ratio (TTM)||4,453.00|
|Earnings Date||Aug 8, 2019|
|Forward Dividend & Yield||1.92 (4.28%)|
|1y Target Est||50.86|
Cardinal Health Inc. is making changes to senior leadership as two top executives plan to leave for other companies next month, and CEO Mike Kaufmann temporarily takes double duty.
DUBLIN, Ohio, July 16, 2019 /PRNewswire/ -- Cardinal Health (CAH) today announced that Stephen Mason, President of the company's Cardinal Health at-Home Solutions business, has been promoted to Chief Executive Officer of Cardinal Health's Medical segment. Mr. Mason will succeed Jon Giacomin, who will be departing the company in mid-August to assume a CEO position at a privately-held company. Mr. Mason is a highly accomplished 20-year veteran of Cardinal Health and has successfully led several businesses within both Cardinal Health's Medical and Pharmaceutical segments.
Zacks.com featured highlights include: Antero Resources, Avis Budget, NOW, Cardinal Health and Asbury Automotive
The task of designing one's portfolio to include potential outperformers is anything but easy. Broker advice helps to design a winning portfolio.
Shares of drug distributors and pharmacy-benefit-manager owners got a boost on Thursday after the Trump administration said it would be withdrawing its plan to overhaul the rebates that drugmakers give to middlemen in Medicare.
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cardinal Health Inc NYSE:CAHView full report here! Summary * Perception of the company's creditworthiness is neutral * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for CAH with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $4.66 billion over the last one-month into ETFs that hold CAH are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is strong relative to the trend shown over the past year. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. CAH credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Shares of health companies were down Monday, with both the Health Care Select Sector SPDR Fund ETF and the SPDR S&P Pharmaceuticals ETF falling 0.6% in morning intraday trade. Shares of Cardinal Health Inc. led the losers in the S&P 500's health-care ETF, falling 3.1% after the company said CFO Jorge Gomez would leaving the company, followed by declines in shares of Incyte Corp , Alexion Pharmaceuticals Inc. , and Biogen Inc. , Regeneron Pharmaceuticals Inc. and Amgen Inc. . The dip in health-care stocks comes after President Trump's announcement Friday that he was planning to soon issue an executive order allowing the U.S. to buy drugs based on the lowest price paid by other developed countries. "Our guess is drug stocks may be initially pressured this week," Jefferies health-care trading desk strategist Jared Holz wrote in an email to clients on Sunday evening. However, "feedback already suggests investors believe the executive order, if it comes to pass, will only be relevant for a handful of drugs (those that are very significant in revenue and administered in a physician's office)... at least at the onset," he wrote. The drop in health shares comes amid a broader decline in U.S. stocks, as investors grapple with doubts about whether the Federal Reserve will still cut interest rates after a strong U.S. jobs report Friday. The S&P 500 was down 0.4% Monday morning. The index has gained 18.8% in the year to date.
Dental products maker Dentsply Sirona Inc. said Monday it has appointed Jorge Gomez, former chief financial officer of Cardinal Health Inc. as its CFO. The announcement came shortly after Cardinal Health said Gomez was leaving on Aug. 9. Dentsply shares were not active premarket, but have gained 55% in 2019, while the S&P 500 has gained 19.3%.
Cardinal Health Inc. said Monday that Chief Financial Officer Jorge Gomez is leaving the company effective Aug. 9. The company said his departure is not related to "any financial performance, policy or control issues or any disagreement on accounting or financial reporting matters." Chief Executive Michael Kaufmann will assume the role of interim CFO, Kaufman has been CEO since January of 2019, but was CFO in the period from Nov. 2014 through Dec. 2017. Shares were not active premarket but have gained 8% in 2019, while the S&P 500 has gained 19.3%.
DUBLIN, Ohio , July 8, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2019 on August 8 prior to the opening of trading ...
Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment. However, integration risks remain a concern.
Amgen produces relatively few drugs, but that's doesn't mean it's any less essential or profitable. Here's a look at the $120B company.
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because they are without peer in the resources they use to identify the best investments for their chosen investment horizon. Moreover, they are more willing to […]
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
DUBLIN, Ohio, May 30, 2019 /PRNewswire/ -- Oncologists said they see a growing role for artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research from Cardinal Health Specialty Solutions. When asked about the future impact of AI on the oncology industry, 53 percent of participating oncologists said they are "excited." More than half of oncologists said they anticipate AI will help enhance the quality of care (53 percent), improve clinical outcomes, and (57 percent) drive operational efficiencies (58 percent) in three or more years. Nearly half (47 percent) also expect it to lower the cost of care.
An introduction to health care companies that are tops in their fields. From health care provider to pharmaceuticals, these companies have the largest global presence according to market capitalization. Learn who these health care giants are and why they may be a good investment.